Ravi Salgia to Proteasome Inhibitors
This is a "connection" page, showing publications Ravi Salgia has written about Proteasome Inhibitors.
Connection Strength
0.075
-
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.
Score: 0.075
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.